@article{74486ce469004ee59dee4264c8a68a08,
title = "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients",
author = "I.E.L.M. Kuppens and E.O. Witteveen and R.C. Jewell and S.A Radema and E.M. Paul and S.G. Mangum and J.H. Beijnen and E.E. Voest and J.H.M. Schellens",
note = "1078-0432",
year = "2007",
language = "Undefined/Unknown",
volume = "13",
pages = "3276--3285",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "11",
}